BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao F, Bian X, Wang J, Xu D, Guo W, Jiang H, Zhao G, Zhu L, Wang S, Xing D, Gao Y, He J, Lu Z. Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma. Front Oncol 2021;11:561247. [PMID: 33842305 DOI: 10.3389/fonc.2021.561247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Misbah M, Kumar M, Lee K, Shen S, Ergün S. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer. BioMed Research International 2022;2022:1-20. [DOI: 10.1155/2022/3825760] [Reference Citation Analysis]
2 Fang Y, Fang D. Comprehensive analysis of placental gene-expression profiles and identification of EGFR-mediated autophagy and ferroptosis suppression in intrahepatic cholestasis of pregnancy. Gene 2022;834:146594. [PMID: 35643225 DOI: 10.1016/j.gene.2022.146594] [Reference Citation Analysis]
3 Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 2022;12:952371. [DOI: 10.3389/fonc.2022.952371] [Reference Citation Analysis]
4 Yao J, Wu XY, Yu Q, Yang SF, Yuan J, Zhang ZQ, Xue JS, Jiang Q, Chen MB, Xue GH, Cao C. The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Sci Adv 2022;8:eabn6928. [PMID: 35622925 DOI: 10.1126/sciadv.abn6928] [Reference Citation Analysis]
5 Dervovic D, Chen EL, Malik A, Afiuni-zadeh S, Boucher J, Berman JM, Teng K, Ayyaz A, Lü Y, Narimatsu M, Mbamalu G, Loganathan S, Martinez S, Tsai R, Lee JB, Zhang L, Wrana J, Roux PP, Jackson HW, Schramek D. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.. [DOI: 10.1101/2022.03.13.484176] [Reference Citation Analysis]
6 Xiang J, Wang K, Tang N. PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.02.010] [Reference Citation Analysis]
7 Sebestyén A, Dankó T, Sztankovics D, Moldvai D, Raffay R, Cervi C, Krencz I, Zsiros V, Jeney A, Petővári G. The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues. Cancer Metastasis Rev. [DOI: 10.1007/s10555-021-10006-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Leithner K. New roles for gluconeogenesis in vertebrates. Current Opinion in Systems Biology 2021;28:100389. [DOI: 10.1016/j.coisb.2021.100389] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhu XR, Peng SQ, Wang L, Chen XY, Feng CX, Liu YY, Chen MB. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Cell Death Dis 2021;12:918. [PMID: 34620839 DOI: 10.1038/s41419-021-04201-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]